Related Experiment Video

Updated: May 21, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

341

Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy

Abhinav Sehgal1, Graham Peigh2, Jeremiah Wasserlauf3

  • 1Division of Medicine, Northwestern University, 251 East Huron Street Suite 8-300, Chicago, IL 60611, USA.

Heart Failure Clinics
|March 19, 2025
PubMed

Insights

Atrial and ventricular arrhythmias worsen outcomes in ischemic cardiomyopathy (ICM). Early rhythm control with catheter ablation shows promise for atrial arrhythmias, while novel strategies are emerging for ventricular tachycardia in ICM.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Arrhythmias

Background:

  • Atrial and ventricular arrhythmias frequently occur in patients with ischemic cardiomyopathy (ICM).
  • These arrhythmias significantly contribute to increased symptoms, morbidity, and mortality in ICM patients.
  • Understanding the interplay between ICM and arrhythmias is crucial for effective patient management.

Purpose of the Study:

  • To review the pathophysiology, evaluation, and treatment of atrial and ventricular arrhythmias in the context of ICM.
  • To highlight recent advancements in diagnostic strategies and catheter-based interventions for these arrhythmias.
  • To discuss emerging research in arrhythmia management for patients with ICM.

Main Methods:

  • Literature review focusing on recent studies and emerging research.
  • Analysis of current diagnostic techniques for evaluating arrhythmias in ICM.
  • Examination of established and novel catheter-directed therapeutic interventions.

Main Results:

  • Early rhythm control via catheter ablation for atrial fibrillation/atrial flutter demonstrates benefits in mortality and symptoms.
  • Ongoing research into scar characterization for improved primary prevention of ventricular tachycardia.
  • Exploration of novel ablation technologies and strategies for ventricular tachycardia treatment.

Conclusions:

  • Catheter ablation for atrial arrhythmias in ICM offers significant clinical advantages.
  • Advancements in scar imaging and ablation techniques are poised to improve ventricular tachycardia management in ICM.
  • A comprehensive approach integrating novel strategies is essential for managing arrhythmias in ischemic cardiomyopathy.

Keywords:
ArrythmiaAtrial fibrillationCatheter ablationEvaluationIschemic cardiomyopathyManagementVentricular tachycardia

More Related Videos

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.4K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.2K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
864
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
785
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
159
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
695
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479